NEWS

Prothena Corp, Prothena Biosciences enter letter agreement with Boehringer Ingelheim

Thursday, Apr 13, 2017

Prothena Corporation - on April 5, 2017, co and Prothena Biosciences entered letter agreement with Boehringer Ingelheim Biopharmaceuticals GMBH.

Prothena Corp - Boehringer Ingelheim reserved for Prothena capacity to manufacture and supply bulk drug substance of NEOD001, PRX003, possibly additional biologics.

Prothena Corp - under agreement, Prothena made commitments for purchase of products from Boehringer Ingelheim.

 

Source: reuters.com

Other News